Print Page   |   Contact Us   |   Sign In   |   Register
Board of Directors

The Board of Directors is the ultimate governing authority of the Sarnoff Cardiovascular Research Foundation. Its mission is to govern the Foundation, protect the organization's image and assets, and be the moral voice of the Sarnoff community.

The Articles of Incorporation and Bylaws of the foundation require that a majority of seats on its Board of Directors shall be persons nominated by the foundation's designated medical institutions ("Publicly Supported Organizations," defined in the Internal Revenue Code). Dr. Sarnoff's successor nominates candidates for the remaining positions on the Board. Elected members who were nominated by the PSOs shall always constitute a majority of the Board. Director vacancies are filled on an annual basis; the Directors serve staggered terms. The present Board consists of fifteen voting members. The Executive Director serves as a non-voting member. 

The Board of Directors of the Sarnoff Cardiovascular Research Foundation, a 501(c)(3) public charity, is required to be controlled by Directors who are nominated to the Board by Publicly Supported organizations (PSOs), as that term is defined in the Internal Revenue Code. PSOs must be actively engaged in developing, encouraging and maintaining a cardiovascular science program in the United States. The ten nominating PSOs of the Foundation are: Columbia University, Duke University, Johns Hopkins University, Mount Sinai Medical Center, Northwestern University, University at Buffalo, University of Iowa, University of Texas Southwestern Medical Center, University of Washington and Vanderbilt University. These ten PSOs are thus entitled to nominate candidates for election to the Board of Directors. The Permanent Successor to Dr. Stanley J. Sarnoff nominates the remaining candidates for election to the Board of Directors. The current Permanent Successor to Dr. Stanley J. Sarnoff is Dr. Jon Lomansey.

 

 

E. Dale Abel, MD, PhD
Chair

Dr. Abel is the Director of the Fraternal Order of Eagles (FOE) Diabetes Research Center and the John B. Stokes III, Endowed Chair in Diabetes Research at the University of Iowa Carver College of Medicine. He is also professor in the Department of Internal Medicine and Chief of the Division of Endocrinology and Metabolism, and has a joint appointment as professor in Biochemistry. Dr. Abel received his medical degree from the University of West Indies in Kingston, Jamaica and was a Rhodes Scholar. Dr. Abel is a past chair of the Scientific Committee.

Nomination Source:  Vanderbilt
Term ends: 2017

H. Scott Baldwin, MD
Immediate Past Chair

Dr. Baldwin is Professor of Cell and Developmental Biology and the Katrina Overall McDonald Professor of Pediatrics at Vanderbilt University School of Medicine. He also serves as the Division Chief of Pediatric Cardiology and the Vice Chair of Pediatric Lab Services at the Vanderbilt University Medical Center. Dr. Baldwin received his medical degree from the University of Virginia. He is a former Chair of the Scientific Committee.
Nomination Source:  Permanent Successor
Term ends: 2019

 



Daniel Garry, MD, PhD
Vice Chair

Dr. Garry is the St. Jude Medical Endowed Chair in Cardiology, Director, Lillehei Heart Institute and Chief, Cardiovascular Division, Department of Medicine at the University of Minnesota. He received his MD and PhD from the University of Minnesota and pursued postdoctoral training at UT Southwestern Medical Center at Dallas. He is a former Chair of the Scientific Committee.

Nomination Source:  University of Iowa
Term ends: 2017

 

 
Jon Lomasney, MD
Permanent Successor

Dr. Lomasney is Associate Professor, Department of Pathology and Department of Molecular Pharmacology and Biological chemistry at Northwestern University Medical School. He received his medical degree from Dartmouth and completed his residency at Johns Hopkins. He was a Sarnoff Fellow and Sarnoff Scholar at Duke University Medical Center. He served on the Scientific Committee from 1993-96.
Nomination Source:  Permanent Successor
Term ends: N/A. Permanent successor to Dr. Stanley J. Sarnoff

 

 
Wendy Post, MD 
Secretary

Dr. Post is Professor of Medicine in the Cardiology Division at the Johns Hopkins University in Baltimore, MD.  She completed medical school at Columbia University, College of Physicians and Surgeons, internal medicine internship and residency at the Beth Israel Hospital, Harvard University, and cardiology fellowship at Johns Hopkins University.  She also received a Masters Degree in Epidemiology from the Harvard School of Public Health. Dr. Post is a former member of the Scientific Committee.

Nomination Source:  Johns Hopkins
Term ends: 2017

 

 
Ricardo Guerra, MD 
Treasurer


Dr. Rich Guerra is Cardiologist at North Texas Heart Center and currently serves as the Chief of Cardiology for the Medical Center of McKinney.  He is a graduate of Harvard University and received his medical degree at the University of California, San Francisco.  His internship and residency were at UCSF, followed by Cardiovascular Disease Fellowship at Stanford University and Interventional Cardiology Fellowship at Vanderbilt University.  Dr. Guerra is a former Sarnoff Fellow and Scholar. 

Nomination Source:  Permanent Successor
Term ends: 2017

 

 

 

 

 

Joseph Hill, MD, PhD

Dr. Hill is Professor Internal Medicine and Molecular Biology, Chief of Cardiology at the UT Southwestern Medical Center and Director of the Harry S. Moss Heart Center. He was graduated from Duke University with MD and PhD degrees in 1987. Dr. Hill is the Chair of the Development Committee, a member of the Audit Committee and former member of the Scientific Committee. 

Nomination Source:  University of Texas Southwestern
Term ends: 2017


 

 

 

Tim Kamerzell, MD, PhD

 

Dr. Kamerzell is a physician scientist at Washington University School of Medicine in St. Louis. He is former Sarnoff Fellow and the current Chair of the Alumni Committee.

Nomination Source:  Chiar, Alumni Committee

Term Ends:  2017

 

 

 

  

  

Thomas Michel, MD

 

Dr. Michel is Professor of Medicine and Biochemistry at Harvard Medical School, Senior Physician in Cardiovascular Medicine at Brigham and Women's Hospital, and Associate Director of the Harvard-MIT MD/PhD Program.  He holds an MD and PhD from Duke University.  Dr. Michel is the current Chair of the Scientific Committee.

Nomination Source:  Chair, Scientific Committee

Term Ends:  2017



 

Daniel Rader, MD


Dr. Rader is the Edward S. Cooper, M.D./Norman Roosevelt and Elizabeth Meriwether McLure Professor of Medicine at the University of Pennsylvania School of Medicine. He also serves as the Director of Preventive Cardiovascular Medicine and Lipid Clinic with the University of Pennsylvania Health System. Dr. Rader is a former Chair of the Scientific Committee and a former Sarnoff Sponsor. 

Nomination Source:  Johns Hopkins
Term ends: 2018

 

 

John Stone, MBA

Before retiring Mr. Stone was the Senior Associate Vice President, Chief Administrative Officer and Chief Financial Officer of The Ohio State University Medical Center (OSUMC). Prior to joining OSUMC, Mr. Stone spent ten years as a consultant responsible for project direction and/or analysis of the operational and financial and components of consulting engagements.

Nomination Source:  Permanent Successor
Term ends: 2017

 

 


Philip Tsao, PhD

Dr. Tsao is Professor in the at the Stanford School of Medicine. Dr. Tsao received his PhD in cardiovascular physiology from Thomas Jefferson University in Philadelphia and was a postdoctoral scholar at Stanford before joining the faculty. He is a former Chair of the Scientific Committee, Sarnoff Fellowship Sponsor and Preceptor.
Nomination Source:  University of Washington
Term ends: 2018
 
 

 

 

 

   

Membership Management Software Powered by YourMembership  ::  Legal